Simon is a seasoned market access leader with a significant track record of success within the Pharmaceutical and Life Science industries, advising clients throughout the market access journey; from asset strategy development to peak sales optimization.
Simon has successfully led strategic market access projects across multiple therapeutic areas, delivering numerous HTA’s, commercial negotiations and pricing strategies across a range of therapeutic areas, including hematology, oncology, ophthalmology, neurology, and rare diseases. He specializes in optimizing assets from early market access strategy through to HTA delivery, reimbursement, commercial negotiation, and implementation, ensuring patient access and commercial success.
Prior to joining Putnam, Simon’s career has seen him successfully lead a boutique multi-practice European consultancy, worked in numerous roles at small and large pharmaceutical companies, the medical device industry and digital health.